Our Lifecycle Management Programs
-
Indication Prioritization / Optimization
Maximize your brand’s chances of success at launch and its commercial potential through the entire product lifecycle. We enable a systematic evaluation of options to ensure you make the right choice of indication/s from launch onwards.
-
Early Lifecycle Strategy
Build and enhance lifecycle management plans for your pre-launch and early post-launch assets. We’ll help you strategically optimize long-term plans to maximize the value of your product across the whole lifecycle. We give you the capability for cross-functional collaboration and alignment.
-
Late Lifecycle Strategy
Strategically prepare for and navigate key loss of exclusivity events. We’ll help you identify and plan for a range of LOE scenarios and give you the means to develop a late-lifecycle strategy that optimizes global and local management of your established portfolios.
-
Commercial Strategy Planning For LOE
Maintain and reinforce the value of your assets through loss of exclusivity. When LOE is looming, we’ll help you develop and implement a globally coordinated, locally executed workstream that will empower your teams.
Programs that are designed to solve the challenges you are facing
Our programs
Brand/ Portfolio Objectives
Key Business Situations
Brand/ Portfolio Objectives
Identify and understand the full range of asset indications for consideration and evaluation
Understand therapeutic potential based on based on the mechanism of action.
Compare the range of potential indications for an asset
Consider market attractiveness, success probabilities, alignment with franchise and/ or corporate goals.
Identify priority indication(s) for initial launch
Assess opportunity vs. risk trade-off to prioritize launch indications and those to reserve for LCM planning.
Understand future indication expansion pathways
Map indication sequencing strategy options from lead launch indication.
Key Business Situations
Launch indication planning
For pre-clinical assets.
Development of first iteration LCM plan
For early-stage assets.
Revisit and pressure-test existing LCM plan
For early-stage assets.
Due diligence
For business development/ licensing opportunities.
Brand/ Portfolio Objectives
Early lifecycle management plan development
Enable cross-functional alignment on priority LCM tactics for pre-launch assets as part of an overarching LCM strategy.
Beyond-indication early LCM planning for a pre-launch asset
Develop a bespoke where-to-play/ how-to-win strategic framework to guide LCM investment decisions to maximize patient experience.
Early LCM plan post-launch audit and optimization
Optimize LCM strategy given post-launch market dynamics perspectives.
Key Business Situations
Speak to our Align's experts
Contact us to develop a robust early lifecycle strategy.
Brand/ Portfolio Objectives
Optimize brand strategy to navigate diversity in late lifecycle dynamics across local markets
Understand how different these might be.
Understand most appropriate business models to guide LLC planning
Consider local differences in patient needs, competitive dynamics and policy/access.
Develop local plans for post-LOE environment
Optimize through LOE events.
Measure success of the brand post-LOE
Based on optimum metrics.
Key Business Situations
Development of global LOE strategic plans
From 2-3 years before first LOE in a major market through to 1-2 years post-LOE.
Health-check on existing late-lifecycle management plans
For late-stage assets.
Development of local LLC plans
By applying global guidance.
Brand/ Portfolio Objectives
Developmental late lifecycle strategy planning/ long-range LoE preparation
Prepare for LoE by developing long-term LLC tactical options for assets 6-7 years prior to LoE.
Scenario planning & risk mitigation
Enable informed decision making and management of uncertainty by developing LLC scenarios that consider direct and indirect LOE events.
Established brand/ portfolio management
Support development/optimization of global operating models for established brand management and pressure test at local level.
Key Business Situations
Speak to our Align's experts
Contact us to develop a robust late lifecycle strategy.
AlignOn: Lifecycle Management
Lifecycle Management (LCM)
Six Strategy Decision Points for Effective Lifecycle Management
Maximise pharma asset value with our infographic: Six Strategic Decision Points for balanced Lifecycle Management success.
Lifecycle Management (LCM)
5 Best Practices In Late Lifecycle Management
Navigate brand challenges with tailored Lifecycle Management. Explore 5 key practices for success as your portfolio evolves.
Lifecycle Management (LCM)
PM360 – When it Comes to Lifecycle Management, Integrate, Don’t Ignore Uncertainty
Discover PM360 Resource on Integration for Lifecycle Management Success. Neal Hansen from Align Strategy explains how effective risk integration enhances planning.
Maximize Your Asset Value Through Lifecycle Management Excellence
We tailor our approach to shape insight-led LCM strategies that account for external dynamics and internal priorities. With our support you can kick-start your lifecycle planning or stress-test your existing plans to sustain your assets’ lasting success.
Key Expertise & Experience In This Area
Our expert consultants will support your teams through our practical, solutions-focused programs, exploring your unique challenges and bringing lasting value to your business.
Align your brand and portfolio needs with a winning strategy
